Understanding Endometriosis Diagnosis Methods

Jun 11, 2026

Decoding Endometriosis Diagnosis

Decoding Endometriosis Diagnosis

Endometriosis is a complex condition affecting at least 1 in 10 women and commonly resulting in considerable pain and infertility. Familiarity with diagnostic options is essential to enable timely, evidence-based treatment. This article examines key symptoms, standard diagnostic procedures, and the contribution of TIER-1 non-invasive diagnostic tests such as electroviscerography (EVG) tests for earlier detection. Current diagnostic pathways relying on TIER-2 and TIER-3 diagnostic procedures are prolonged and encounter multiple barriers in public healthcare; this overview is intended to inform both patients and clinicians regarding symptom recognition, diagnostic approaches, benefits of adding TIER-1 testing to the diagnostic pathway, and recommended referral processes following diagnosis.

What Are the Key Symptoms Indicating Endometriosis?

Endometriosis produces a spectrum of symptoms that can markedly impair quality of life. Early recognition of these clinical features facilitates appropriate medical assessment. Common presentations include:

  1. Pelvic Pain : Often the most prominent symptom, pelvic pain can occur during menstruation, intercourse, or bowel movements. Symptom progression includes increase pain levels and pain duration, which can lead to chronic pain.
  2. Menstrual Irregularities : Many women with endometriosis experience heavy periods (menorrhagia) or bleeding between periods.
  3. Gastrointestinal Symptoms : Symptoms such as bloating, diarrhea, constipation, and nausea can also be associated with endometriosis. Endometriosis patients often have an IBS diagnosis.

Accurate recognition of these symptoms supports earlier intervention and long-term management.

Which Diagnostic Procedures Are Standard for Endometriosis Detection in Canada?

Diagnosis typically combines a structured clinical evaluation with targeted diagnostic procedures. Standard approaches include:

  1. Preliminary Diagnosis Methods : Initial assessments often involve a thorough medical history and pelvic examination to identify signs of endometriosis.
  2. Imaging Techniques : Advanced ultrasound (tranvaginal ultrasound or TVUS) and MRI are commonly used to visualize endometrial tissue and assess the extent of the disease.
  3. Diagnostic Laparoscopy as the Gold Standard : This minimally invasive surgical procedure allows for direct visualization of endometrial implants and can provide histopathologic confirmation.

How Is Laparoscopy Utilized as an Invasive Diagnostic Method?

Laparoscopy is regarded as the diagnostic gold standard because it enables direct visualization of pelvic structures. Around 85% of patients have lower-stage superficial endometriosis (also known as peritoneal endometriosis) which can’t reliably be imaged using TIER-2 diagnostic imaging like TVUS and MRI, leaving surgery as the gold standard to conclusively confirm disease. The procedure involves insertion of a laparoscope through a small abdominal incision to identify endometrial implants external to the uterus and to obtain tissue for histopathological confirmation. Although laparoscopy provides high diagnostic accuracy, it remains an invasive intervention with it’s own risks, and may not be appropriate for all patients.

Evidence supports the diagnostic precision of laparoscopy in detecting endometriotic lesions.

Laparoscopy: Standard for Endometriosis Diagnosis Accuracy

Laparoscopy is the standard method to visually identify endometriotic lesions under magnification within and outside the minor pelvis. The aim of this study was to analyze the accuracy of laparoscopic visualization in diagnosing the various endometriotic sites as confirmed histologically.

Accuracy of laparoscopic diagnosis of endometriosis, 2003

What Imaging Techniques Support Endometriosis Diagnosis?

TIER-2 imaging modalities are integral when laparoscopy is not immediately indicated. Transvaginal ultrasound (TVUS) commonly serves as the first-line modality for detecting more advanced disease such as ovarian endometriomas and deep infultrating endometriosis. MRI provides high-resolution assessment of pelvic anatomy and disease extent. Both modalities have limitations; diagnostic performance for TVUS varies with operator expertise and lesion characteristics.

Recent reviews highlight ongoing advancements in imaging modalities that may expand their non-invasive detection capabilities.

Imaging Modalities for Non-Invasive Endometriosis Detection

“None of the evaluated imaging modalities were able to detect overall pelvic endometriosis with enough accuracy that they would be suggested to replace surgery.”

Imaging modalities for the non‐invasive diagnosis of endometriosis, V Nisenblat, 2016

Now That TIER-1 Testing is Available, Can Non Invasive Tests Enhance Early Detection of Endometriosis?

Non-invasive diagnostic methods contribute to earlier detection of endometriosis. Their primary advantages include:

  1. Rapid Diagnosis : Non-invasive methods can provide quicker results compared to traditional invasive procedures.
  2. Early Diagnosis: These tests can be used on any age female-born patient, closing the diagnostic gap and allowing for preventative treatment and symptom management.
  3. Accessibility of Tests : Many non-invasive tests can be performed in outpatient settings, making them more accessible to patients.
  4. Cost-Effectiveness : These tests often reduce the need for more expensive and invasive diagnostic procedures.

What Is the Clinical Evidence Supporting EVG Testing (ENDOSURE TEST)?

EVG, or electroviscerography, is an analytical instrument used to collect gastro-intestinal myolectric actitivty (GIMA) from muscle cells that line the intestine. In 1998, gastroenterologists realized the GIMA profile was altered in patients with endometriosis, and later found GIMA biometrics could be attained non-invasively using EVG.

Most similar to an electrocardiogram (ECG) but for the gut, ENDOSURE testing uses 30-minutes of GIMA information collected through EVG to identify if the subject has a specific GIMA profile unique to endometriosis and/or adenomyiosis sufferers, and known as the “GIMA of endometriosis”. The pivotal study identifying the GIMA biomarker for endometriosis was published in 2024, followed by interim results from several independent validation studies world-wide, which supported the pivotal results, by the fall of 2025.

The pivotal study reports sensitivity of 95% and specificity of 96% for patients aged 35 & under (91%/95% for those 36years+). [2] Validation studies interim results commonly reported 100% selectivity against laparoscopic surgery but could not provide specificity as studies lacked a benign cohort. [3,4,5]

EVG is a simple technology and doesn’t rely on several different biomarkers to detect disease presence. Instead, EVG simply records a patient’s GIMA for 30-minutes then takes less than 5 seconds to detect the GIMA biomarker of endometriosis. Results provide clinicians with data to inform diagnostic and management decisions. Known as the ENDOSURE test, EVG is the ONLY TIER-1 test available worldwide and authorized for sale by Health Canada, the UK and is CE Marked for Europe.

EVG research into GIMA biomarker of endometriosis represents a significant effort to identify non-surgical diagnostic alternatives.

“Basically, the ENDOSURE test measures the prostaglandins effect on the electricity on the bowel. ”

Dr. Sam Azer, OBGYN, Edmonton AB

What Are the Recommended Referral Pathways Following Diagnosis?

Following confirmed diagnosis, establishing structured referral pathways is essential to ensure comprehensive care. Recommended components include:

  1. Path to Treatment : Patients should be referred to a specialist who can provide tailored treatment options, including medical management and possibly surgical interventions.
  2. Access to Fertility Specialists : If symptoms include infertility, a referral to a gynecologists or reproductive endocrinologists with expertise in endometriosis are crucial for effective management.
  3. Team approach: Dieticians, physical therapists, psychologist and pain management specialists support patients who've experienced long diagnostic delays while disease progresses.
  4. Utilization of ENDOSURE Testing : Incorporating the ENDOSURE test into the diagnostic process can eliminate the diagnostic gap to 30-minutes, enhance accuracy diagnosis and inform treatment strategies and allow for preventative treatment.

Frequently Asked Questions

What lifestyle changes can help manage endometriosis symptoms?

Lifestyle modification can be part of symptom management after a diagnosis. Regular physical activity may reduce pelvic pain and improve general health. A diet emphasizing anti-inflammatory foods—such as fruits, vegetables, and foods high in omega-3 fatty acids—may provide symptomatic benefit for some patients. Structured stress-management interventions, including relaxation techniques and counseling, can be useful adjuncts. Clinicians should guide development of individualized plans based on symptom profile and comorbidities.

Are there any alternative therapies for endometriosis?

Some patients pursue complementary therapies alongside conventional treatment, including acupuncture, herbal preparations, and dietary supplements. Limited clinical studies report potential analgesic effects from acupuncture and improvements in quality-of-life measures in selected cohorts; however, the evidence base is variable. Discussion with a treating clinician is necessary to evaluate safety, potential interactions, and suitability for individual patients.

How does endometriosis affect fertility?

Endometriosis can impair fertility through scarring, adhesions, and inflammatory changes that affect ovarian function, tubal patency, and endometrial receptivity. These pathological processes can interfere with ovulation, fertilization, and implantation. Estimates indicate infertility in approximately 30–40% of affected women. Many patients experiencing infertility do achieve pregnancy with endometriosis specific infertility treatment, following surgical removal of endometrial lesions or using assisted reproductive technologies such as in vitro fertilization.

What are the long-term health implications of untreated endometriosis?

Untreated endometriosis may result in chronic pelvic pain, infertility, and formation of ovarian cysts. Epidemiological studies have identified associations between endometriosis and certain other conditions, including a potential increased risk of ovarian neoplasms in specific subgroups. The chronic course of the disease can also contribute to psychological comorbidity, including anxiety and depression. Early diagnosis and appropriate management reduce long-term morbidity and improve patient outcomes.

Can endometriosis symptoms change over time?

Endometriosis symptoms may fluctuate over time. Some patients experience remission of symptoms, whereas others report progression. Hormonal fluctuations, aging, pregnancies and disease evolution influence symptom trajectory. Regular clinical monitoring and ongoing communication with treating clinicians are necessary to adjust management strategies as indicated.

What role does genetics play in endometriosis?

Genetic factors contribute to susceptibility to endometriosis. A positive family history is associated with increased risk, and specific genetic variants have been linked to the condition. Genetic predisposition operates in concert with environmental exposures and lifestyle factors in the onset and progression of disease.

Conclusion

Comprehensive understanding of diagnostic modalities for endometriosis supports timely and effective treatment and informs clinical decision-making. Recognition of characteristic symptoms combined with application of TIER-1 diagnostics like EVG, can enable more rapid and accurate diagnosis and improve management outcomes. TIER-2 testing for disease mapping is requisite if surgical removal of endometrial lesions is indicated. For further information and clinical resources, consult our repository of endometriosis materials.

1. Nisenblat, V., Bossuyt, P. M. M., Farquhar, C., Johnson, N., & Hull, M. L. (2016). Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database of Systematic Reviews, 2016(2), CD009591. https://doi.org/10.1002/14651858.CD009591.pub2

2. Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. . 2024; 13(10):2866. https://doi.org/10.3390/jcm13102866

Journal of Clinical Medicine

3. Tanos P, Donders F, Massaro A …

Defining the Role of the Gastrointestinal Myoelectrical Activity (GIMA) Biomarker in the Diagnosis of Endometriosis.

Journal of Minimally Invasive Gynecology, 32S23

4. Noar M, Mathias J, Kolatkar A. Validation of new GIMA biomarker signature of endometriosis: interim data. Published online. Accessed June 11, 2026. https://www.longdom.org/open-access/validation-of-new-gima-biomarker-signature-of-endometriosis-interim-data-1099894.html

5. EndoDiagnosis. Research. Accessed June 11, 2026. https://endodiagnosis.com/research/